FEMY · Forms 3, 4, 5
Insider trades at FEMASYS INC
5 insiders bought $134K of FEMASYS INC stock on the open market in the last 90 days.
Every Form 3, 4 and 5 filed for FEMASYS INC (FEMY) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Kenneth D. Eichenbaum | Director | Options or other derivatives | Form 4 | ||||
| Edward R Uzialko | Director | Options or other derivatives | Form 4 | ||||
| Alistair Milnes | Director | Options or other derivatives | Form 4 | ||||
| Charles Larsen | Director | Options or other derivatives | Form 4 | ||||
| Jeffrey Gerald Mifek | Chief Clinical-Medical Affairs | Options or other derivatives | Form 4 | ||||
| Jeffrey Gerald Mifek | Chief Clinical-Medical Affairs | Became an insider (Form 3) | Form 3 | ||||
| Jeffrey Gerald Mifek | Chief Clinical-Medical Affairs | Buy | 3,125 | $3.20 | $10K | Form 4 | |
| Jeremy Alexander Sipos | Chief Technology Officer | Buy | 3,125 | $3.20 | $10K | Form 4 | |
| John Charles Canning | Chief Operating Officer | Buy | 4,375 | $3.20 | $14K | Form 4 | |
| Dov Elefant | Chief Financial Officer | Buy | 15,625 | $3.20 | $50K | Form 4 | |
| Kathy Lee-Sepsick | Chief Executive Officer | Buy | 15,625 | $3.20 | $50K | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.